Search Results - "Brooks, DJ"
-
1
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
Published in Annals of neurology (01-03-2006)“…Objective Glial cell line–derived neurotrophic factor (GDNF) exerts potent trophic influence on midbrain dopaminergic neurons. This randomized controlled…”
Get full text
Journal Article -
2
Compulsive drug use linked to sensitized ventral striatal dopamine transmission
Published in Annals of neurology (01-05-2006)“…Objective A small group of Parkinson's disease (PD) patients compulsively use dopaminergic drugs despite causing harmful social, psychological, and physical…”
Get full text
Journal Article -
3
The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study
Published in Brain (London, England : 1878) (01-04-2005)“…Opioids have been shown to provide symptomatic relief from dysaesthesias and motor symptoms in restless legs syndrome (RLS). However, the mechanisms by which…”
Get full text
Journal Article -
4
Reward Processing in Health and Parkinson’s Disease: Neural Organization and Reorganization
Published in Cerebral cortex (New York, N.Y. 1991) (01-01-2004)“…It has been suggested that motivational processes mediated by dopaminergic neural systems may be relatively spared in Parkinson’s disease (PD) and activation…”
Get full text
Journal Article -
5
Neuroinflammation in Alzheimer's disease
Published in Lancet neurology (01-04-2015)“…Summary Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the neuronal compartment, but includes strong interactions with…”
Get full text
Journal Article -
6
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
Published in Movement disorders (01-09-2017)“…ABSTRACT This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant history of Dr. James Parkinson's himself and what he…”
Get full text
Journal Article -
7
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0
Published in European journal of nuclear medicine and molecular imaging (01-07-2020)“…Purpose This joint practice guideline or procedure standard was developed collaboratively by the European Association of Nuclear Medicine (EANM) and the…”
Get full text
Journal Article -
8
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
Published in JAMA neurology (01-03-2022)“…One characteristic histopathological event in Alzheimer disease (AD) is cerebral amyloid aggregation, which can be detected by biomarkers in cerebrospinal…”
Get more information
Journal Article -
9
The noradrenergic subtype of Parkinson disease: from animal models to clinical practice
Published in Nature reviews. Neurology (01-06-2023)“…Many advances in understanding the pathophysiology of Parkinson disease (PD) have been based on research addressing its motor symptoms and phenotypes. Various…”
Get full text
Journal Article -
10
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial
Published in The Lancet (British edition) (12-03-2005)“…Rasagiline mesylate is a novel drug for Parkinson's disease with selective, irreversible monoamine oxidase B (MAO-B) inhibitor activity, and is effective as…”
Get full text
Journal Article -
11
Imaging markers for Alzheimer disease: Which vs how
Published in Neurology (30-07-2013)“…Revised diagnostic criteria for Alzheimer disease (AD) acknowledge a key role of imaging biomarkers for early diagnosis. Diagnostic accuracy depends on which…”
Get full text
Journal Article -
12
In vivo imaging of microglial activation with [ 11C]( R)-PK11195 PET in idiopathic Parkinson's disease
Published in Neurobiology of disease (01-02-2006)“…Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder associated with akinesia, tremor and rigidity. While the characteristic Lewy body pathology…”
Get full text
Journal Article -
13
Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease
Published in Journal of neurology (01-08-2012)“…Differences in the expression of non-motor symptoms (NMS) by Parkinson’s disease (PD) patients may have important implications for their management and…”
Get full text
Journal Article -
14
Daily leptin blunts marrow fat but does not impact bone mass in calorie-restricted mice
Published in Journal of endocrinology (01-06-2016)“…Starvation induces low bone mass and high bone marrow adiposity in humans, but the underlying mechanisms are poorly understood. The adipokine leptin falls in…”
Get full text
Journal Article -
15
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
Published in Alzheimer's & dementia (01-07-2018)“…Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer's disease (AD), but its prevalence is unclear because earlier studies did not require…”
Get full text
Journal Article -
16
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe
Published in Human brain mapping (01-08-2003)“…Probabilistic atlases of neuroanatomy are more representative of population anatomy than single brain atlases. They allow anatomical labeling of the results of…”
Get full text
Journal Article -
17
DLB and PDD boundary issues : Diagnosis, treatment, molecular pathology, and biomarkers
Published in Neurology (13-03-2007)“…For more than a decade, researchers have refined criteria for the diagnosis of dementia with Lewy bodies (DLB) and at the same time have recognized that…”
Get full text
Journal Article -
18
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
Published in Nature medicine (01-05-2003)“…Glial cell line-derived neurotrophic factor (GDNF) is a potent neurotrophic factor with restorative effects in a wide variety of rodent and primate models of…”
Get full text
Journal Article -
19
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
Published in Annals of neurology (01-07-2003)“…Preclinical studies suggest ropinirole (a D2/D3 dopamine agonist) may be neuroprotective in Parkinson's disease (PD), and a pilot clinical study using 18F‐dopa…”
Get full text
Journal Article -
20
Positron Emission Tomography and Single-Photon Emission Computed Tomography in Central Nervous System Drug Development
Published in NeuroRx (01-04-2005)“…In this review, the value of functional imaging [positron emission tomography (PET)/single-photon emission computed tomography (SPECT)] in drug development is…”
Get full text
Journal Article